NCT01372306

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Dr.Reddy's Laboratories, Ltd. and Janssen Pharmaceutical Products, l.P. (Reminyl®)4 mg Galantamine HBr Tablets in Healthy Adult Male Volunteers Under Fed Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Dr. Reddy's Laboratories Limited · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Galantamine Hydrobromide Tablets, Bioequivalence study of Dr. Reddy's under Fed condition.

Detailed description

Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Dr.Reddy's Laboratories, ltd. and Janssen Pharmaceutical Products, l.P. (Reminyl®)4 mg Galantamine HBr Tablets in Healthy Adult Male Volunteers under Fed Conditions

Conditions

• Fed

Interventions

Type	Name	Description
DRUG	Reminyl	Galantamine Hydrobromide Tablets of Dr. Reddy's Laboratories Limited

Timeline

• Start date: 2004-10-01
• Primary completion: 2004-11-01
• Completion: 2004-11-01
• First posted: 2011-06-13
• Last updated: 2011-06-30